SG11202000415PA - Transdermal delivery system with a microporous membrane having solvent-filled pores - Google Patents

Transdermal delivery system with a microporous membrane having solvent-filled pores

Info

Publication number
SG11202000415PA
SG11202000415PA SG11202000415PA SG11202000415PA SG11202000415PA SG 11202000415P A SG11202000415P A SG 11202000415PA SG 11202000415P A SG11202000415P A SG 11202000415PA SG 11202000415P A SG11202000415P A SG 11202000415PA SG 11202000415P A SG11202000415P A SG 11202000415PA
Authority
SG
Singapore
Prior art keywords
solvent
delivery system
microporous membrane
transdermal delivery
filled pores
Prior art date
Application number
SG11202000415PA
Inventor
Eun Soo Lee
Amit K Jain
Parminder Singh
Original Assignee
Corium Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corium Inc filed Critical Corium Inc
Publication of SG11202000415PA publication Critical patent/SG11202000415PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
SG11202000415PA 2017-07-26 2018-07-26 Transdermal delivery system with a microporous membrane having solvent-filled pores SG11202000415PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762537414P 2017-07-26 2017-07-26
PCT/US2018/043961 WO2019023499A1 (en) 2017-07-26 2018-07-26 Transdermal delivery system with a microporous membrane having solvent-filled pores

Publications (1)

Publication Number Publication Date
SG11202000415PA true SG11202000415PA (en) 2020-02-27

Family

ID=63165550

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202000415PA SG11202000415PA (en) 2017-07-26 2018-07-26 Transdermal delivery system with a microporous membrane having solvent-filled pores

Country Status (10)

Country Link
US (2) US20190029971A1 (en)
EP (1) EP3658127A1 (en)
JP (2) JP2020529229A (en)
KR (1) KR20200032153A (en)
CN (1) CN111132669A (en)
AU (1) AU2018307792A1 (en)
CA (1) CA3071007A1 (en)
MX (1) MX2020000651A (en)
SG (1) SG11202000415PA (en)
WO (1) WO2019023499A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102419767B1 (en) 2016-06-23 2022-07-12 코리움, 인크. Adhesive matrix containing hydrophilic and hydrophobic domains and therapeutic agents
CA3032103A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Memantine transdermal delivery systems
EP3490540A1 (en) 2016-07-27 2019-06-05 Corium International, Inc. Sodium bicarbonatein situ
CA3086163A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
CA3154505A1 (en) * 2019-10-24 2021-04-29 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of fingolimod
IL309454A (en) 2021-06-28 2024-02-01 Corium Llc Corona discharge treated transdermal delivery system
CN117915898A (en) 2021-06-28 2024-04-19 考里安有限责任公司 Combination therapy treatment using transdermal delivery systems

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4880633A (en) * 1986-03-12 1989-11-14 Merck & Co., Inc. Transdermal drug delivery system
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
JPH06199659A (en) * 1992-10-28 1994-07-19 Hisamitsu Pharmaceut Co Inc Apparatus for percutaneous treatment
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
CA2208132A1 (en) * 1994-12-21 1996-06-27 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
MXPA02000053A (en) * 1999-07-05 2003-07-21 Idea Ag A method for the improvement of transport across adaptable semi-permeable barriers.
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
EP1390085B1 (en) 2001-05-01 2009-08-05 A.V. Topchiev Institute of Petrochemical Synthesis Hydrogel compositions
ATE399026T1 (en) 2003-11-21 2008-07-15 Memory Pharm Corp COMPOSITIONS CONTAINING L-TYPE CALCIUM CANAL BLOCKERS AND CHOLINESTERASE INHIBITORS
RU2428179C2 (en) * 2006-05-08 2011-09-10 Тейкоку Сейяку Ко., Лтд. Preparative forms of medications against dementia for transcutaneous introduction
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
KR101454362B1 (en) * 2008-03-24 2014-10-23 아이큐어 주식회사 Percutaneous absorption preparations for the treatment of dementia containg donepezil as an active ingredient
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
WO2011034323A2 (en) * 2009-09-16 2011-03-24 Samyang Corporation Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP5699554B2 (en) 2010-11-11 2015-04-15 富士通株式会社 Vector processing circuit, instruction issue control method, and processor system
CN113797180A (en) * 2014-12-18 2021-12-17 Icure药品株式会社 Percutaneous absorption preparation containing donepezil as active ingredient
EP3310348B1 (en) * 2015-06-22 2020-08-05 Corium, Inc. Transdermal adhesive composition comprising a poorly soluble therapeutic agent
IL260290B2 (en) * 2015-12-30 2023-11-01 Corium Inc Systems and methods for long term transdermal administration
EP3490540A1 (en) * 2016-07-27 2019-06-05 Corium International, Inc. Sodium bicarbonatein situ

Also Published As

Publication number Publication date
JP2023171749A (en) 2023-12-05
WO2019023499A1 (en) 2019-01-31
CN111132669A (en) 2020-05-08
US20190029971A1 (en) 2019-01-31
RU2020108005A3 (en) 2021-11-30
RU2020108005A (en) 2021-08-26
KR20200032153A (en) 2020-03-25
EP3658127A1 (en) 2020-06-03
AU2018307792A1 (en) 2020-02-06
MX2020000651A (en) 2020-07-29
CA3071007A1 (en) 2019-01-31
US20240016759A1 (en) 2024-01-18
JP2020529229A (en) 2020-10-08

Similar Documents

Publication Publication Date Title
SG11202000415PA (en) Transdermal delivery system with a microporous membrane having solvent-filled pores
GB201805261D0 (en) Membranes
GB201719767D0 (en) Membrane
EP3195922A4 (en) Porous membrane
EP3328310C0 (en) Sub-atmospheric wound therapy systems and methods
EP3302751A4 (en) Porous bodies with enhanced pore architecture
GB2571428B (en) GC-IMS interface comprising semi-permeable membrane for blocking transmission
GB201721320D0 (en) Membrane
EP3411137C0 (en) Ceramic selective membranes
EP3592700A4 (en) Permeable graphene and permeable graphene membranes
IL258025B (en) A drip emitter and a membrane for a drip emitter
SG10201504770TA (en) Hydrophilic block copolymers and membranes prepared therefrom (ii)
EP3349737A4 (en) Transdermal delivery system
EP3441133A4 (en) Semipermeable membrane
EP3162432A4 (en) Composite semipermeable membrane
EP3328522A4 (en) Osmotic desalination methods and associated systems
GB201705030D0 (en) Membranes for filtering organic solutions
EP3252855A4 (en) Porous carbon sheet and precursor fiber sheet thereof
SG10201504716UA (en) Hydrophilic block copolymers and membranes prepared therefrom (i)
HUE051691T2 (en) Porous hollow fiber membrane
PL3242552T3 (en) Gas delivery device comprising a gas releasing molecule and a gas permeable membrane
EP3572144A4 (en) Semipermeable membrane and uses thereof
EP3225299A4 (en) Multilayer semipermeable membrane
EP3445771A4 (en) Biocompatible polymeric membranes
GB201604949D0 (en) Composite membranes